Andrade Robert
CHIEF FINANCIAL OFFICER
Andrade Robert has filed 19 SEC Form 4 filings (23 transaction rows) across 1 company, with disclosures dating back to 2025. 18 of those filings fall inside the rolling window. Most recent filing: Sep 1, 2026.
On the most recent filing, Andrade Robert is listed as CHIEF FINANCIAL OFFICER at FENNEC PHARMACEUTICALS INC. Inside the rolling window, Andrade Robert reported no open-market purchases and 1 open-market sale totaling $884K in FENC.
Companies traded
Other insiders at FENC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$884K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Andrade Robert made?
Andrade Robert has filed 19 SEC Form 4 filings (23 transaction rows) across 1 company since 2025.
Which companies does Andrade Robert trade?
Andrade Robert has filed SEC Form 4 disclosures for 1 company, including FENC.
When was Andrade Robert's most recent SEC Form 4 filing?
Andrade Robert's most recent SEC Form 4 filing on Tracefour is dated Sep 1, 2026.
What is Andrade Robert's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Andrade Robert is listed as CHIEF FINANCIAL OFFICER.
What is Andrade Robert's total buy and sell value in the current window?
Inside the rolling retention window, Andrade Robert bought $0 and sold $884K based on SEC Form 4 filings.
What was Andrade Robert's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 75,000 FENC shares on 2026-08-27, worth $884K, per SEC Form 4 filings.